Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof
TW202629146APending Publication Date: 2026-07-16ENSYSCE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115113127
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-03-09
- Filing Date
- 2022-03-09
- Publication Date
- 2026-07-16
Abstract
Aspects of the present disclosure include pharmaceutical compositions, and their methods of use, where the pharmaceutical compositions include an active agent prodrug that provides enzymatically-controlled release of an active agent, and controlled release nafamostat or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art